23 results
Thumbnail

D3.126 - Evaluation of Severe Pediatric Asthma Response to Biologics Using the Pediatric CONFiRM Score: A Real-Life Cohort Analysis

Thumbnail

D3.127 - Evaluation of Serum Ezrin Levels and Spirometric and Plethysmographic Tests in Patients with Allergic and Non-Allergic Asthma

Thumbnail

D3.128 - Management of Nasal Polyposis in Moderate-Severe Asthma Patients With Aspirin Desensitization And Biologic Agent Combination: Our Real-Life Experience With Seven Cases

Thumbnail

D3.129 - Evaluation of Cardiovascular Disease Risk and Associated Factors in Childhood Asthma

Thumbnail

D3.130 - PGI2 Signaling Attenuates the Proliferation and Type 2 Cytokine Production of Group 2 Innate Lymphoid Cells

Thumbnail

D3.131 - Comparative Assessment of Exercise Provocation, and Impulse Oscillometry in Young Adults With Exercise-Induced Respiratory Symptoms

Thumbnail

D3.132 - The impact of biological therapy on the quality of life of patients with severe asthma

Thumbnail

D3.133 - Clinical Impact of Cumulative Oral Corticosteroid Exposure in Patients with Severe Asthma: Data from the Korean Severe Asthma Registry

Thumbnail

D3.134 - Pulmonary rehabilitation at altitude: Is there an optimal season?

Thumbnail

D3.135 - Real World Efficacy of Benralizumab Treatment in Severe Eosinophilic Asthma: A Single-Center Experience

Thumbnail

D3.137 - The “Street Cat” Paradox: Low Prevalence but High Disease Burden of Mouse Sensitization in Pediatric Asthma

Thumbnail

D3.138 - Can FeNO predict lung function decline in asthma? A 5-year multicenter cohort study

Thumbnail

D3.139 - Asthma control and medication adherence in patients with asthma using preferred versus alternative GINA treatment tracks - a real-world observational study

Thumbnail

- D3.540 - Sources of IL-13 in Acute Versus Chronic Models of Eosinophilic Esophagitis

Thumbnail

- D3.538 - Aeroallergen sensitisation as a risk factor for paediatric eosinophilic esophagitis

Thumbnail

- D3.539 - Evaluation of Treatment Selection and Response in Patients with Eosinophilic Esophagitis Based on Clinical Findings and Allergy Testing

Thumbnail

- D3.541 - Who takes the patient with eosinophilic esophagitis (EoE) and acute laryngeal edema?

Thumbnail

- D3.542 - Prevalence of sensitization to panallergens and IgG4 profiles against specific foods in patients with allergic-phenotype eosinophilic esophagitis

Thumbnail

- D3.545 - Natural Killer and Dendritic Cells Leverage Synergistic Interactions to Enhance Treatment of Non-Small Cell Lung Cancer

Thumbnail

- D3.544 - Allergic biomarkers and clinical outcomes in lung cancer patients treated with immune checkpoint inhibitors: a pilot study